Leukemias and Blood Cancers 

The Hematologic Malignancies Program, part of the Tisch Cancer Institute at Mount Sinai Health System, provides patient-focused world-class care, provided by highly respected specialists in a convenient and accessible environment. The best cancer care requires highly skilled and compassionate providers who understand the complexity of each patient’s need. Our commitment to whole person care ensures that the entire cancer treatment process is individualized and focused on treating each patient’s physical, emotional and spiritual needs. 

The Hematological Malignancies Program seeks to gain insights that lead to the prevention of cancer and to improve diagnosis and treatment of adult patients with malignancies. The Program engages in a broad range of basic and clinical research, patient care and teaching.

Our physicians have significant expertise in the full range of leukemias and blood cancers, including: 

Multidisciplinary Team Approach 

Our multidisciplinary team approach to care provides access to physicians on the medical staff at Mount Sinai Health System, in a wide array of specialties that include surgical oncologist, medical oncologist, radiation oncologist, hematological oncologist, pathologist and other medical specialists. 

The centerpiece of the clinical cancer program is the tumor boards and multidisciplinary clinics where specialists from medical oncology or bone marrow transplantation evaluate and discuss patients for whom a multidisciplinary approach is being considered. This is extremely beneficial to patients, as multiple experts in several specialty areas collaborate together to provide a personalized treatment plan that takes into consideration their medical history, condition and lifestyle. 

Patients can request that their care be discussed by a tumor board. The multidisciplinary group will collectively design the best course of action for each patient. 

Diagnosis and Treatment 

Although many blood cancer and leukemias may not have symptoms, a person who has symptoms associated with any type of blood cancer (such as swollen lymph nodes, fevers, infections, unexplained fatigue or weight loss or unexplained pain) should immediately seek medical advice. With all cancers, treatment begins with a proper diagnosis. 

The cancer journey can be stressful and intimidating. During this time you will be accepting the news that you have cancer, finding a specialist, getting the correct diagnosis, making treatment choices, beginning treatment. Learning about your cancer can help you make knowledgeable decisions with your doctor about your cancer treatment and take an active role in your ongoing care. At the Hematologic Malignancies Program, we offer comprehensive consultations by board certified specialists and ensure rapid access to needed tests and the most advanced technologies. 

Mount Sinai has experts in multiple myeloma, myelodysplastic syndrome (MDS), myeloproliferative disease (MPD) and other blood cancers and leukemias. We also have a renowned Bone Marrow Transplant Program

Ongoing Research and Clinical Trials 

The basic science and clinical studies that are carried out by hematology faculty cover a broad range of hematologic malignancies and blood disorders. Mount Sinai Health System participates in major multi-center trials conducted by groups such as the National Institutes of Health (NIH) Clinical Trials Network, The Cancer and Leukemia Group B (CALGB). Clinical trials allow patients entry into clinical studies that could change how medicine is practiced in the future. 

Participation in clinical trials is completely voluntary, and access to cutting-edge treatments is one of the benefits afforded to patients at Mount Sinai. For a list of currently open clinical trials please see Clinical Trials and Research Studies at Mount Sinai.

Support for Patients and Caregivers 

We are dedicated to providing the best care to patients and love ones with leukemia, and blood disorders . This includes compassionate nursing, nutritional consultations, counseling services, and support groups. For more information on these services, please see Social Work Services or contact the Derald H. Ruttenberg Treatment Center at 212-241-6756.


Contact Us

To make an appointment:
212-241-6021

In this episode of "Healthy Body, Healthy Mind" Mount Sinai's John Mascarenhas, MD, discusses myelofibrosis - including why it's an unfamiliar term for many people, the rarity of the disease, and the age at which most people are diagnosed. Watch Video